Multiple studies have unveiled critical insights into cancer biology and therapeutics. Indiana University scientists identified dual protein targets to weaken pancreatic cancer cell defenses. University of Basel researchers engineered a fusion protein enhancing cancer immunotherapy by disrupting immune evasion and boosting activation. Duke University pinpointed basal stem-like cells as origins of small-cell lung cancer, providing new angles for treatment. These advances contribute to precision oncology by identifying novel molecular and cellular vulnerabilities.